Clinical study on submucosal injection of pirarubicin combined with instillation of mitomycin after TURBT in patients with non-muscle invasive bladder cancer
-
摘要: 目的: 评价经尿道膀胱肿瘤电切术(TURBT)后即刻黏膜下注射吡柔比星(THP)联合丝裂霉素(MMC)灌注治疗非肌层浸润性膀胱癌患者的疗效和安全性。方法: 63例膀胱尿路上皮细胞癌患者TURBT术中行THP注射后1年内规律MMC膀胱灌注,每周1次连续8周,每2周1次连续8次,每个月1次连续6次,术后每3个月复查膀胱镜。结果: 术后随访2个月~3年,复发率15.9%;灌注期间6例出现不同程度副反应,1例术后8个月发生全身性骨转移,1例术后3年死亡。结论: THP膀胱内注射联合MMC定期灌注用于膀胱癌术后预防肿瘤复发效果明显、安全、可靠。Abstract: Objective: To evaluate the efficacy and safety of immediate submucosal injection of pirarubicin (THP) combined with intravesical instillation of mitomycin (MMC) after TURBT in patients with non-muscle invasive bladder cancer. Method:The data of 63 patients with bladder urothelial cell carcinoma underwent TURBT were retrospectively analyzed. After immediate injected of THP after TURBT, the patients were received postoperative intravesical instillation of MMC once a week for eight weeks, later once every two weeks for four months, and at last once a month for six months. Cystoscopy was taken once every three months postoperatively. Result:The recurrence rate was 15.9% after follow-up period of 2 months-3 years. Six cases of side effects, one case of systemic bone metastasis and one case of death took place during intravesical instillation of MMC within three years postoperatively. Conclusion: Postoperative prophylactic submucosal injection of THP combined with regular intravesical instillation of MMC is effective and safe for prevention of recurence of bladder carcinoma after the operation.Key words bladder cancer; mitomycin; pirarubicin; postoperative instillation
-
Key words:
- bladder cancer /
- mitomycin /
- pirarubicin /
- postoperative instillation
-
-
[1] 陈梓甫.表浅膀胱癌的诊断与治疗[J].临床泌尿外科杂志, 2003, 18 (5):257-258.
[2] Yamamoto Y, Nasu Y, Saika T, et al.The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer[J].BJU Int, 2000, 86 (7):802-804.
[3] 吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社, 2004:974.
[4] Lamm D L.Intravesical therapy for superficial bladder cancer:slow but steady progress[J].J Clin Oncol, 2003, 21 (23):4259-4260.
[5] Sylvester R J, Oosterlinck W, van der Meijden A P.A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer:a meta-analysis of published results of randomized clinical trials[J].J Urol, 2004, 171 (6 Pt 1):2186-2190, quiz 2435.
[6] Usama Sulaiman Al-Nasiri, Wisam Ali Kareem.Effectiveness of immediate mitomycin C instillation in patients with low risk non-muscle invasive bladder cancer[J].The Iraqi Postgraduate Medical Journal, 2009, 8 (4):387-392.
[7] Seok Jin Jung, Hyuk Soo Chang, Choal Hee Park.Effectiveness of an immediate mitomycin C instillation in patients with superficial bladder cancer receiving periodic mitomycin C instillation[J].Korean J Urol, 2011, 52 (5):323-326.
[8] 王建国, 张先觉, 陈士祥, 等.吡柔比星术后早期与常规膀胱灌注化疗治疗浅表性膀胱癌的疗效分析[J].临床泌尿外科杂志, 2012, 27 (8):588-590.
[9] 田军, 李长岭, 马建辉, 等.羟基喜树碱术后即刻灌注联合维持灌注预防非浸润性膀胱癌复发的长期疗效分析[J].中国肿瘤临床, 2012, 39 (2):105-106, 109.
[10] 赵铁军.白介素-2联合应用吡柔比星预防膀胱肿瘤术后复发[J].第四军医大学学报, 2006, 27 (11):F0003-F0003.
[11] Rajala P, Liukkonen T, Raitanen M, et al.Transurethral resection with perioperative instillation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer:aprospective randomized multicenter study——Finnbladder III[J].J Urol, 1999, 161 (4):1133-1135;discussion 1135-1136.
[12] 陈晓, 王飚, 田惠忠.经尿道膀胱肿瘤电切术后膀胱黏膜下注射抗肿瘤药物防治肿瘤复发.中华外科杂志, 2004, 42 (10):580-582.
[13] 姚剑.表阿霉素黏膜下浸润注射加单次灌注预防浅表性膀胱癌术后复发的研究[J].中华泌尿外科杂志, 2004, 25 (10):679-681.
[14] 宋兆录, 刘镇, 彭传真, 等.术中黏膜下注射与术后即刻灌注吡柔比星预防表浅性膀胱癌术后复发的疗效比较[J].现代泌尿外科杂志, 2011, 16 (1):45-46.
[15] Peter Whelan.The treatment of non-muscle-invasive bladder cancer with intravesical chemotherapy and immunotherapy[J].Eur Urol, 2007, Suppl 6:568-571.
-
计量
- 文章访问数: 243
- PDF下载数: 157
- 施引文献: 0
下载: